These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways. Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765 [TBL] [Abstract][Full Text] [Related]
27. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens. Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148 [TBL] [Abstract][Full Text] [Related]
28. Activation of Antigen-Specific CD8(+) T Cells by Poly-DL-Lactide/Glycolide (PLGA) Nanoparticle-Primed Gr-1(high) Cells. Luo WH; Yang YW Pharm Res; 2016 Apr; 33(4):942-55. PubMed ID: 26715415 [TBL] [Abstract][Full Text] [Related]
29. Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. Kurts C; Klebba I; Davey GM; Koch KM; Miller JF; Heath WR; Floege J Kidney Int; 2001 Aug; 60(2):664-71. PubMed ID: 11473649 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Clarke SR; Barnden M; Kurts C; Carbone FR; Miller JF; Heath WR Immunol Cell Biol; 2000 Apr; 78(2):110-7. PubMed ID: 10762410 [TBL] [Abstract][Full Text] [Related]
31. CD8 T cell priming by B lymphocytes is CD4 help dependent. Castiglioni P; Gerloni M; Cortez-Gonzalez X; Zanetti M Eur J Immunol; 2005 May; 35(5):1360-70. PubMed ID: 15816014 [TBL] [Abstract][Full Text] [Related]
32. Development of memory CD8+ T cells and their recall responses during blood-stage infection with Plasmodium berghei ANKA. Miyakoda M; Kimura D; Honma K; Kimura K; Yuda M; Yui K J Immunol; 2012 Nov; 189(9):4396-404. PubMed ID: 23008449 [TBL] [Abstract][Full Text] [Related]
33. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
34. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045 [TBL] [Abstract][Full Text] [Related]
35. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Bertolino P; Trescol-Biémont MC; Rabourdin-Combe C Eur J Immunol; 1998 Jan; 28(1):221-36. PubMed ID: 9485202 [TBL] [Abstract][Full Text] [Related]
36. Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells. van den Berg H; Greuter M; Kraal G; den Haan JM Immunobiology; 2010; 215(2):163-71. PubMed ID: 19278748 [TBL] [Abstract][Full Text] [Related]
37. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. Martinez-Kinader B; Lipford GB; Wagner H; Heeg K Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131 [TBL] [Abstract][Full Text] [Related]
38. Effective Delivery of Antigen-Encapsulin Nanoparticle Fusions to Dendritic Cells Leads to Antigen-Specific Cytotoxic T Cell Activation and Tumor Rejection. Choi B; Moon H; Hong SJ; Shin C; Do Y; Ryu S; Kang S ACS Nano; 2016 Aug; 10(8):7339-50. PubMed ID: 27390910 [TBL] [Abstract][Full Text] [Related]
39. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets. Wang W; Golding B Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814 [TBL] [Abstract][Full Text] [Related]
40. Constitutive class I-restricted exogenous presentation of self antigens in vivo. Kurts C; Heath WR; Carbone FR; Allison J; Miller JF; Kosaka H J Exp Med; 1996 Sep; 184(3):923-30. PubMed ID: 9064352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]